Pepdexpepdex

VIP (Vasoactive Intestinal Peptide) Mistakes to Avoid

What are the most common mistakes with VIP (Vasoactive Intestinal Peptide)?

The most common VIP (Vasoactive Intestinal Peptide) mistakes are running VIP for CIRS without doing the upstream Shoemaker prep first; stopping too early (CIRS courses run months); treating it as a general anti-inflammatory rather than a specific protocol piece. Most issues people run into come down to protocol and expectations, not the compound itself. Going in informed matters here because human evidence for VIP (Vasoactive Intestinal Peptide) is limited.

Common VIP (Vasoactive Intestinal Peptide) mistakes

  • Running VIP for CIRS without doing the upstream Shoemaker prep first
  • Stopping too early (CIRS courses run months)
  • Treating it as a general anti-inflammatory rather than a specific protocol piece

Bloodwork worth tracking

  • MMP-9, C4a, TGF-β1 in CIRS context (Shoemaker panel)
Pepdex is an editorial reference, not medical advice. Peptides vary in legal and approval status by country, many are research compounds without full human safety data. Talk to a qualified clinician before starting anything.

Last updated 2026-06-15.